Abstract
Maple syrup urine disease (MSUD) is an autosomal recessive inborn error disorder derived from the accumulation of the branched-chain amino acids (BCAAs) leucine, isoleucine and valine. Either the E1α, E1β or DBT (E2) genes are responsible for this neurometabolic disease. Here, we report the identification and characterization of a novel E2 gene 4.7 kb deletion as a rare nonhomologous recombination of the long interspersed nuclear elements 1 (LINE-1) in intron 10 and the Alu in the 3′ UTR of the E2 gene from three classic MSUD patients of the Austronesian aboriginal tribe Paiwan in Taiwan. The E2 gene 4.7 kb deletion accounted for five out of six alleles in the three unrelated Paiwanese MSUD patients, indicating a founder effect. Carrier-frequency study revealed one deleted heterozygote out of 101 normal Paiwanese. As the nine Taiwanese Austronesian aboriginal tribes share a common origin, this E2 4.7 kb deletion may be preserved in some of the other Austronesian aboriginal tribes of Taiwan. This is the first comprehensive genetics study of MSUD in the Austronesian tribal groups as well as in Taiwan.
Similar content being viewed by others
Introduction
Maple syrup urine disease (MSUD; types Ia MIM#248600, Ib MIM#248611 and II MIM# 248610), a metabolic disease that was first described by Menkes et al,1 is an autosomal recessive inborn error disorder resulting from the defective activity of mitochondrial branched-chain α-ketoacid dehydrogenase (BCKAD), which catabolizes the oxidative decarboxylation of branched-chain α-ketoacids (BCKAs) from the branched-chain amino acids (BCAAs) leucine, isoleucine and valine.2 Mutations in any of the E1α or E1β or DBT (dihydrolipoamide branched chain transacylase, E2) components of the BCKAD complex can result in classic, intermediate or intermittent MSUD.3 Clinically, MSUD patients manifest with poor feeding, lethargy, seizures, developmental delay, psychomotor retardation, coma or death. Early diagnosis is essential to decrease morbidity and mortality. Molecular analysis of MSUD may be beneficial for early genetic counseling.
MSUD appears in all ethnic groups with a general incidence of less than 1 in 185 000 newborn infants in the general population.2 Two founder mutations of MSUD in specific populations have been reported: An E1α Y393N mutation in the Old Order Mennonite population at a frequency of 1/1764 and an E1β R183P mutation in Ashkenazi Jews at a frequency of 1/113.5 Here, we report a novel E2 gene 4.7 kb founder deletion caused by an unusual nonhomologous recombination between the long interspersed nuclear elements 1(LINE-1) and Alu in three classic MSUD patients of the aboriginal tribe Paiwan. We also present the molecular characterization of the deletion breakpoints as well as the carrier frequency of this deletion in the tribe Paiwan, one of the nine Austronesian aboriginal tribes in Taiwan.
Materials and methods
Mutation analysis of the MSUD patients
Three unrelated classic form MSUD cases, one boy (patient 1) and two girls (patients 2 and 3), were documented in terms of clinical symptoms and abnormal elevation of plasma BCAAs. All patients belonged to the aboriginal tribe Paiwan of Taiwan. Genomic DNA was extracted from peripheral blood by the salting-out method. The intronic PCR primers were derived from Homo sapiens chromosome 19 working draft sequence segment (Gene Bank GI: 12741466) and Homo sapiens chromosome 6 working draft sequence segment (Gene Bank GI:12731894) to amplify all exons of E1α and E1β genes, respectively for sequence analysis (primer sequences are available by request). The E2 gene mutation analysis of genomic DNA was performed as previously described.6 The amplicons were sequenced bidirectionally with the ABI PRIAM 3100 genetic analyzer (Applied Biosystems, Foster City, CA, USA). The primer set DelF (5′-TTCTGCAGGTCTGCTGGAGT-3′) and DelB (5′-TGAGATGGCGTCTTGCTCTG-3′) were used for amplification of the deleted allele. The PCR was annealed at 64°C for 40 s and extended for 50 s at 72°C.
Heterozygote detection of the E2 4.7 kb deletion and carrier-frequency determination in the Paiwan population
The heterozygote of the E2 gene 4.7 kb deletion was detected with genomic DNA by duplex PCR with primers DelF, DelB, Ex11F (5′-CATTTCTAGGCCATTCCCCG-3′) and Ex11B (5′-TGCTGGCACAGCTAGGGTTT-3′), as previously described. The carrier-frequency study by duplex PCR was carried out with the approval of the Ethical Committee of the Taichung Veterans General Hospital. The geographic range included in our study was the mountainous area in Taitung County, one of the indigenous habitats of the tribe Paiwan in Southeastern Taiwan. A total of 242 blood samples were collected. The subjects of this study were unrelated individuals whose parents were both Paiwanese. A total of 101 unrelated normal Paiwanese including 67 female and 34 male subjects were enrolled. Informed consent was obtained from all participants and all personal identifiers were stripped from the samples for the carrier analysis.
Results
MSUD E1α, E1β and E2 gene mutation analysis
Molecular analysis revealed no mutation in either the E1α or the E1β genes of all the three Paiwanese MSUD patients. Patient 2 carried a heterozygous 2-bp (AT) deletion (c.88-89delAT) in exon 2 of the E2 gene, causing a frame shift downstream of residue (−26) in the mitochondrial targeting presequence7 (Figure 1a). No further E2 sequence variation was found in this patient. For patients 1 and patient 3, exon 11 of the E2 gene could not be amplified from genomic DNA with the primer set 11f–E2-3′,6 although it was amplified successfully in patient 2 and normal controls. In attempting to achieve a successful exon 11 amplification, several genomic DNA PCR primer sets extending 2 kb beyond both coding region ends of exon 11 (Gene Bank GI: 22041703) were tried; however, negative PCR results were still obtained. We therefore postulated that there might be a homozygous deletion starting from somewhere around intron 10 of the E2 gene in patients 1 and 3.
Determination of the E2 4.7 kb deletion and the carrier study
Primers DelF and DelB flanking the deletion junction were defined from patients 1 and 3 after several rounds of the PCR walking approach (data not shown). The sequences of amplicon DelF–DelB revealed a 4741 bp genomic DNA deletion spanning position 49273 to position 54013 (Homo sapiens chromosome 1 working draft sequence segment, Gene Bank-NT_028050, GI: 22041703) (Figure 1b) or the (IVS10 -4140–1del;c.1296-1896del) mutation (Gene Bank NT_028050, GI: 22041703; Homo sapiens dihydrolipoamide branched-chain transacylase mRNA, Gene Bank GI:4503264), which includes the 3′ half of intron 10, the entire coding region of the terminal exon 11 and the 5′ part of the 3′ UTR of the E2 gene (Figure 2a).
The composition of the repeated elements in the E2 gene was analyzed with REPEATMASKER (http://repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker) to determine if repeated elements were involved in this deletion event. We found that Alus comprised 21.4% and LINES comprised 21.6% of the E2 gene. A centromerically oriented 6.4 kb long interspersed nuclear elements 1 (LINE-1) occupied about 60% of intron 10. The 3′ UTR sequences of this LINE-1 revealed that it belonged to the L1PA7 family. In the 3′ UTR of the E2 gene, four Alu elements, Alu Sx, Alu Jo, Alu Sx and Alu Jo, are arranged in that order (Figure 2a). The 5′ breakpoint of this E2 4.7 kb deletion occurred in ORF1 of the L1PA7, while the 3′ breakpoint was located in the right arm of the first Alu Sx in the E2 3′ UTR (data not shown).
Duplex PCR was used to detect the heterozygous deletion status of the alleles. The primer set Ex11F–Ex11B served as the internal control to amplify exon 11 and DelF–DelB was used to amplify the deletion junction fragment. For normal alleles, the primer set Ex11F–Ex11B produces a 244-bp amplicon of exon 11, and Ex11F–DelB generates a 750-bp PCR fragment. The primer combinations of DelF–DelB and DelF–Ex11B were amplified unsuccessfully because of the nearly 5 kb distance between the forward and backward primers on the normal allele. For the deleted allele, a 388-bp fragment from the primer pair DelF–DelB was generated (Figure 2a). Patients 1 and 3 generated only a 388-bp fragment from duplex PCR analysis, indicating that both of them were E2 gene 4.7 kb deletion homozygotes. Patient 2, an AT 2-bp deleted heterozygote, showed a heterozygous E2 gene 4.7 kb deletion (Figure 2b).
The E2 4.7 kb deletion accounted for five out of six alleles in three Paiwanese MSUD patients revealing a founder effect of this deletion in the Paiwan population. Carrier-frequency study identified one E2 4.7 kb deleted heterozygote among 101 unrelated healthy aboriginal Paiwanese.
Characterization of the deletion
The sequences around the deletion junction showed two overlapped base pairs (gt) at the deletion junction (Figure 1b and 3) and no significant homology between this L1PA7 and Alu Sx, indicating a nonhomologous recombination event (Figure 3). The recombination related elements appeared around the 5′or 3′ breakpoints (Figure 3) and are summarized in Table 1.
Discussion
Several different types of small mutations have previously been reported in the E2 gene.6,7,12,13,14 However, large deletion of the E2 gene has only been reported once as a 15–20 kb genomic DNA loss resulting from the recombination between an intronic Alu in intron 6 and the coding sequences of the terminal exon 11.15 Here we report another large fragment deletion in the E2 gene. This E2 4.7 kb genomic DNA deletion may lead to failure to splice intron 10 or to alternative splicing of intron 10 with several possible cryptic splice acceptor sites in the nondeleted intron 10 or nondeleted 3′UTR according to the analysis with BDGP: Splice Site Prediction by Neural Network (http://www.fruitfly.org/seq_tools/splice.html) (data not shown). The mutated E2 protein may have amino acids replaced or deleted after Lys366 (Figure 2a), thus it may lose the His391 active site12 of the E2 catalytic domain resulting in the enzymatic inactivation of the E2 protein. The changed or missing amino acids after Lys366 may also destroy the structure of the E2 catalytic domain and disrupt the assembly of intermediated active trimers that interlock through carboxyl-terminal hydrophobic knobs to produce the native 24-meric core,14 thus affecting the assembly of the correct 24-mers cubic structure.
Concerning the 3′ UTR deletion, a major class of regulatory cis elements comprising adenosine–uridine pentamers (AUUUA) termed AU-rich elements (AREs) are repeated once or several times within the 3′UTR and are often found within U-rich regions of mRNA. AREs that function as RNA-destabilizing elements and target mRNA for rapid degradation in the cytoplasm have been found in numerous mRNA species.16 The deleted 3′UTR region of the E2 4.7 kb deletion is a U-rich area containing one ARE pentamer (AUUUA) and one ARE hexamer (AUUUUA). The loss of these two AREs might produce a much more stable mutated E2 mRNA than normal E2 mRNA.
Alus and LINE-1 have been implicated in gene insertion and recombination, and accordingly are associated with several human diseases.17,18,19 Nonhomologous recombination between LINE-1 and Alu causing gene deletion, like the E2 4.7 kb deletion we report here, has only been reported once in the dystrophin gene20 and has never been documented in the MSUD E2 or other genes. The L1PA7 in intron 10 of the E2 gene contains multiple small deletions, insertions and point mutations that leave the ORF1 and ORF2 of L1PA7 truncated (data not shown), indicating that the L1PA7 had lost its transposable activity, and it was thus probably not an active LINE-1. The 3′ breakpoint of this 4.7 kb deletion was located on the right arm of the Alu Sx rather than the left arm, although the Alu recombination hotspots usually occur on the left arm due to the presence of the 26-bp core sequence.21 There was a homologous Alu 26-bp core sequence (22/26) on the right arm of the Alu Sx in the recombining strand (Figure 3). We therefore inferred that Alu might play a role in the E2 4.7 kb deletion.
It is generally agreed that multiple mechanisms are involved in nonhomologous recombination.19 Scaffold/matrix-attached regions (S/MARs) may also be closely related to breakage events and gene recombination.17,19 We used MAR Finder (http://www.futuresoft.org/MAR-Wiz) to analyze the S/MARs potential with the 3′ part of the E2 gene over a 12 kb region encompassing exon 10 to the end of the 3′ UTR including the deletion region; however, no significant MAR potential was predicted at the 5′ or 3′ breakpoint sites (data not shown). The other specific elements including topoisomerase I and II recognition sites, chi-like sequences, direct repeats and inverted repeats that we characterized around the 5′ and 3′ breakpoints have also been implicated in gene recombination.22 However, there is no evidence that these elements and sequence structures directly mediated this particular E2 nonhomologous recombination. We hypothesize that the possible cause of the Alu-LINE-1 associated nonhomologous recombination about this E2 4.7 kb deletion may be the ‘homology-associated nonhomologous recombination’.23
In Taiwan, fewer than 10 MSUD cases without accompanying gene analysis have been reported since 1986,24,25 although the incidence is much higher in the aboriginal tribes of Taiwan according to our data. The E2 4.7 kb deletion we describe here is not only the first MSUD genetic mutation identified in Taiwan but also a founder mutation in the Paiwan tribe. The aboriginal tribes of Taiwan, belonging to the Austronesian family, comprise 1.5% of the total population of Taiwan, and are divided into nine major groups including Amis, Puyuma, Yami, Atayal, Saisiyat, Bunun, Tsao, Rukai and Paiwan. As HLA class I genetic studies have shown, traits are highly homogenous within each tribe but different among tribes, and yet they have affinities to form a cluster together in the population dendrogram due to long-term isolation.26 The tribes regionally distributed throughout the rugged internal mountains and along the eastern coast have individually distinct and sometimes mutually unintelligible languages and different material cultures and social organizations. They have common ancient origins that are temporally and geographically consistent with genetic, linguistic and archaeological studies.27
In addition to the MSUD and the E2 4.7 kb deleted carriers identified in the tribe Paiwan, we also found the same E2 4.7 kb deletion in a carrier of the Puyuma tribe during the study period. This implies that this disease or deletion may also be preserved in some of the other Austronesian aboriginal tribes of Taiwan. We suggest that MSUD gene screening should be provided for the tribe Paiwan and the other Austronesian aboriginal tribes in Taiwan for the further investigation of the E2 gene 4.7 kb deletion status. We believe that this information may also be helpful for the study of MSUD among Austronesian families in other countries.
References
Menkes JH, Hurst PL, Craig JM : A new syndrome progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics 1954; 14: 462–466.
Chuang DT, Shih VE : Disorders of branched chain amino acid and keto acid metabolism; in: Scriver CR, Beaudet A, Sly WL, Valle D (eds): The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001, pp 1971–2006.
Nellis MM, Danner DJ : Gene preference in maple syrup urine disease. Am J Hum Genet 2001; 68: 232–237.
Marshall L, DiGeorge A : Maple syrup urine disease in the Old Order Mennonites. Am J Hum Genet 1981; 33 (Suppl): 139A.
Edelmann L, Wasserstein MP, Kornreich R, Sansaricq C, Snyderman SE, Diaz GA : Maple syrup urine disease identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population. Am J Hum Genet 2001; 69: 863–868.
Chuang JL, Cox RP, Chuang DT : E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype. J Clin Invest 1997; 100: 736–744.
Fisher CW, Fisher CR, Chuang JL, Lau KS, Chuang DT, Cox RP : Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations. Am J Hum Genet 1993; 52: 414–424.
Harada T, Nagayama J, Kohno K, Mickley LA, Fojo T, Kuwano M et al: Alu-associated interstitial deletions and chromosomal re-arrangement in 2 human multidrug-resistant cell lines. Int J Cancer 2000; 86: 506–511.
Been MD, Burgess RR, Champoux JJ : Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. Nucleic Acids Res 1984; 12: 3097–3114.
Sperry AO, Blasquez VC, Garrard WT : Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II. Proc Natl Acad Sci USA 1989; 86: 5497–5501.
Rudiger NS, Gregersen N, Kielland-Brandt MC : One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. Nucleic Acids Res 1995; 23: 256–260.
Chuang DT, Fisher CW, Lau KS, Griffin TA, Wynn RM, Cox RP : Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex. Mol Biol Med 1991; 8: 49–63.
Lebo RV, Shapiro LR, Fenerci EY et al: Rare etiology of autosomal recessive disease in a child with noncarrier parents. Am J Hum Gene 2000; 67: 750–754.
Tsuruta M, Mitsubuchi H, Mardy S, Miura Y, Hayashida Y, Kinugasa A et al: Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex. J Hum Genet 1998; 43: 91–100.
Herring WJ, McKean M, Dracopoli N, Danner DJ : Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease. Biochim Biophys Acta 1992; 1138: 236–242.
Balmer LA, Beveridge DJ, Jazayeri JA, Thomson AM, Walker CE, Leedman PJ : Identification of a novel AU-rich element in the 3′ untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins. Mol Cell Biol 2001; 21: 2070–2084.
Bode J, Benham C, Ernst E, Knopp A, Marschalek R, Strick R et al: Fatal connections: when DNA ends meet on the nuclear matrix. J Cell Biochem 2000; (Suppl 35): 3–22.
Ostertag EM, Kazazian Jr HH : Biology of mammalian L1 retrotransposons. Annu Rev Genet 2001; 35: 501–538.
Van de Water N, Williams R, Ockelford P, Browett P : A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertion. Thromb Haemost 1998; 79: 938–942.
Suminaga R, Takeshima Y, Yasuda K, Shiga N, Nakamura H, Matsuo M : Nonhomologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability. J Hum Genet 2000; 45: 331–336.
Burwinkel B, Kilimann MW : Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease. J Mol Biol 1998; 277: 513–517.
McNaughton JC, Cockburn DJ, Hughes G, Jones WA, Laing NG, Ray PN et al: Is gene deletion in eukaryotes sequence-dependent? A study of nine deletion junctions and nineteen other deletion breakpoints in intron 7 of the human dystrophin gene. Gene 1998; 222: 41–51.
Sakagami K, Tokinaga Y, Yoshikura H, Kobayashi I : Homology-associated nonhomologous recombination in mammalian gene targeting. Proc Natl Acad Sci USA 1994; 91: 8527–8531.
Feng KP, Chow KW, Chan YP : Maple syrup urine disease in Chinese. Chin Med J 1986; 99: 119–120.
Lin MC, Chen CH, Fu LS, Jan SL, Shu SG, Chi CS : Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case. Acta Paediatr Taiwanica 2002; 43: 281–284.
Lin M, Chu CC, Lee HL, Chang SL, Ohashi J, Tokunaga K et al: Heterogeneity of Taiwan's indigenous population: possible relation to prehistoric Mongoloid dispersals. Tissue Antigens 2000; 55: 1–9.
Melton T, Clifford S, Martinson J, Batzer M, Stoneking M : Genetic evidence for the proto-Austronesian homeland in Asia: mtDNA and nuclear DNA variation in Taiwanese aboriginal tribes. Am J Hum Genet 1998; 63: 1807–1823.
Acknowledgements
We thank the subject families for their participation, Dr Tsung-Lung Wu, Dr Yu-Ling Hsiao, Miss Yu-Ling Hsu, Miss Ching-Yu Chen and Miss Chin-Hsuan Chen for processing the blood samples, as well as Dr De-Xiong Ba and the nurses of the Taimali Health Center for communication. The Taichung Veterans General Hospital Research Program TCVGH-906516D supported the present study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chi, CS., Tsai, CR., Chen, LH. et al. Maple syrup urine disease in the Austronesian aboriginal tribe Paiwan of Taiwan: a novel DBT (E2) gene 4.7 kb founder deletion caused by a nonhomologous recombination between LINE-1 and Alu and the carrier-frequency determination. Eur J Hum Genet 11, 931–936 (2003). https://doi.org/10.1038/sj.ejhg.5201069
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5201069
Keywords
This article is cited by
-
Imaging findings of anaplastic astrocytoma in a child with maple syrup urine disease: a case report
Child's Nervous System (2015)
-
Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan
Journal of Inherited Metabolic Disease (2010)
-
Animal models of maple syrup urine disease
Journal of Inherited Metabolic Disease (2009)
-
Maple syrup urine disease due to a new large deletion at BCKDHA caused by non‐homologous recombination
Journal of Inherited Metabolic Disease (2008)